Genetic Determinants Of Response To Patritumab Deruxtecan (Her3-Dxd) In  Hormone Receptor-Positive/Her2-Negative (Hr+/Her2-) Breast Cancer: A Correlative Analysis From Solti Tot-Her3 Trial
Patritumab Deruxtecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Genetic Determinants Of Response To Patritumab Deruxtecan (Her3-Dxd) In  Hormone Receptor-Positive/Her2-Negative (Hr+/Her2-) Breast Cancer: A Correlative Analysis From Solti Tot-Her3 Trial ### Output: Patritumab Deruxtecan